A research and development proposal for the purpose of detecting markers contained in nonpalpable breast cancer lesions using a magnetic probe was adopted by the Development of Medical Devices through Collaboration between Medicine and Industry of the Japan Agency for Medical Research and Development (AMED). Matrix Cell Research Institute Inc. will serve as the representative organization.